Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Melatonin and Rivotril Treatment for Idiopathic Rapid Eye Movement Sleep Disorder: Prospective Randomized Study.
Conditions
Interventions
Melatonin 2mg
ClonazePAM 0.5 MG
Locations
1
South Korea
Kyung Hee University Hospital at Gangdong
Seoul, South Korea
Start Date
November 9, 2017
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
February 21, 2021
NCT06441864
NCT06467461
NCT06193252
NCT05471960
NCT06270290
NCT06745011
Lead Sponsor
Kyung Hee University Hospital at Gangdong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions